Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.4 USD | +9.18% | +9.45% | +106.57% |
12/04 | EZZ Life Science Completes AU$854,000 Placement with Kingstone Venture Capital | MT |
10/04 | Kingstone Companies, Inc. Appoints Manmohan Singh to Its Board of Directors | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 190.1 | 83.58 | 70.99 | 52.42 | 14.42 | 22.92 |
Enterprise Value (EV) 1 | 198.2 | 81.85 | 82.12 | 58.75 | 27.85 | 39.23 |
P/E ratio | 61.1 x | -14 x | 73.9 x | -7.14 x | -0.64 x | -3.71 x |
Yield | 2.26% | 4.19% | 2.74% | 3.2% | 8.89% | - |
Capitalization / Revenue | 1.67 x | 0.57 x | 0.54 x | 0.33 x | 0.11 x | 0.16 x |
EV / Revenue | 1.74 x | 0.56 x | 0.63 x | 0.36 x | 0.21 x | 0.27 x |
EV / EBITDA | 30 x | -24 x | 24.1 x | -13.7 x | -1.23 x | -101 x |
EV / FCF | 12.9 x | 7.42 x | -4.59 x | 2.62 x | -0.82 x | -2.71 x |
FCF Yield | 7.76% | 13.5% | -21.8% | 38.1% | -123% | -36.8% |
Price to Book | 2.14 x | 0.95 x | 0.76 x | 0.69 x | 0.4 x | 0.67 x |
Nbr of stocks (in thousands) | 10,743 | 10,785 | 10,675 | 10,483 | 10,684 | 10,759 |
Reference price 2 | 17.69 | 7.750 | 6.650 | 5.001 | 1.350 | 2.130 |
Announcement Date | 18/03/19 | 16/03/20 | 31/03/21 | 04/04/22 | 31/03/23 | 01/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 113.8 | 145.6 | 131.4 | 161.2 | 130.2 | 144.2 |
EBITDA 1 | 6.616 | -3.41 | 3.403 | -4.293 | -22.62 | -0.3896 |
EBIT 1 | 4.829 | -5.956 | 0.5384 | -7.583 | -25.92 | -3.363 |
Operating Margin | 4.24% | -4.09% | 0.41% | -4.7% | -19.92% | -2.33% |
Earnings before Tax (EBT) 1 | 3.007 | -7.783 | -1.288 | -9.409 | -27.94 | -7.366 |
Net income 1 | 3.093 | -5.966 | 0.9724 | -7.378 | -22.52 | -6.168 |
Net margin | 2.72% | -4.1% | 0.74% | -4.58% | -17.31% | -4.28% |
EPS 2 | 0.2894 | -0.5538 | 0.0900 | -0.7000 | -2.120 | -0.5735 |
Free Cash Flow 1 | 15.39 | 11.03 | -17.89 | 22.38 | -34.14 | -14.45 |
FCF margin | 13.53% | 7.57% | -13.62% | 13.88% | -26.23% | -10.02% |
FCF Conversion (EBITDA) | 232.61% | - | - | - | - | - |
FCF Conversion (Net income) | 497.52% | - | - | - | - | - |
Dividend per Share 2 | 0.4000 | 0.3250 | 0.1825 | 0.1600 | 0.1200 | - |
Announcement Date | 18/03/19 | 16/03/20 | 31/03/21 | 04/04/22 | 31/03/23 | 01/04/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 36.8 | 37.05 | 26.67 | 27.9 | 29.36 | 30.45 | 28.25 | 29.51 | 27.94 |
EBITDA | - | - | - | - | - | - | - | - | - |
EBIT | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -13.68 | 3.014 | -11.67 | -6.782 | -4.559 | -4.935 | -6.304 | -0.5634 | -4.397 |
Net income 1 | -10.62 | 2.228 | -9.198 | -5.38 | -3.998 | -3.95 | -5.055 | -0.522 | -3.538 |
Net margin | -28.85% | 6.01% | -34.48% | -19.28% | -13.62% | -12.97% | -17.89% | -1.77% | -12.66% |
EPS 2 | -1.010 | 0.2100 | -0.8700 | -0.5100 | -0.3800 | -0.3700 | -0.4700 | -0.0500 | -0.3300 |
Dividend per Share | 0.0400 | 0.0400 | 0.0400 | - | - | - | - | - | - |
Announcement Date | 11/11/21 | 10/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 8.16 | - | 11.1 | 6.33 | 13.4 | 16.3 |
Net Cash position 1 | - | 1.74 | - | - | - | - |
Leverage (Debt/EBITDA) | 1.233 x | - | 3.272 x | -1.474 x | -0.5935 x | -41.88 x |
Free Cash Flow 1 | 15.4 | 11 | -17.9 | 22.4 | -34.1 | -14.5 |
ROE (net income / shareholders' equity) | 3.38% | -6.75% | 1.07% | -8.76% | -40.3% | -17.5% |
ROA (Net income/ Total Assets) | 1.16% | -1.27% | 0.11% | -1.46% | -4.97% | -0.66% |
Assets 1 | 267.2 | 471.2 | 923.4 | 505.1 | 453 | 936.2 |
Book Value Per Share 2 | 8.250 | 8.170 | 8.740 | 7.220 | 3.380 | 3.200 |
Cash Flow per Share 2 | 1.970 | 3.000 | 1.830 | 2.320 | 1.120 | 0.8300 |
Capex 1 | 2.73 | 3.94 | 3.33 | 4.5 | 4.55 | 1.83 |
Capex / Sales | 2.4% | 2.71% | 2.53% | 2.79% | 3.5% | 1.27% |
Announcement Date | 18/03/19 | 16/03/20 | 31/03/21 | 04/04/22 | 31/03/23 | 01/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+106.57% | 48.43M | |
+38.91% | 61.52B | |
+10.01% | 50.24B | |
+12.05% | 48.88B | |
+21.50% | 44.86B | |
+22.39% | 33.96B | |
+10.03% | 29.23B | |
+50.11% | 27.95B | |
+21.57% | 24.78B | |
-3.96% | 20.38B |
- Stock Market
- Equities
- KINS Stock
- Financials Kingstone Companies, Inc.